Prognostic significance of chromosome 3 alterations determined by microsatellite analysis in uveal melanoma: a long-term follow-up study

[1]  Mohammed F. Faramawi,et al.  Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma , 2011, Modern Pathology.

[2]  C. Shields,et al.  Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens. , 2011, Ophthalmology.

[3]  B. Damato,et al.  Genotypic Profiling of 452 Choroidal Melanomas with Multiplex Ligation-Dependent Probe Amplification , 2010, Clinical Cancer Research.

[4]  B. Damato,et al.  Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. , 2010, Investigative ophthalmology & visual science.

[5]  J. Harbour,et al.  An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. , 2010, The Journal of molecular diagnostics : JMD.

[6]  A. Stanton,et al.  Reactions to and Desire for Prognostic Testing in Choroidal Melanoma Patients , 2009, Journal of Genetic Counseling.

[7]  B. Damato,et al.  Translating uveal melanoma cytogenetics into clinical care. , 2009, Archives of ophthalmology.

[8]  Arie Perry,et al.  Transcriptomic versus Chromosomal Prognostic Markers and Clinical Outcome in Uveal Melanoma , 2007, Clinical Cancer Research.

[9]  I. Rennie,et al.  Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma , 2006, Eye.

[10]  Justis P. Ehlers,et al.  Gene Expression Profiling in Uveal Melanoma Reveals Two Molecular Classes and Predicts Metastatic Death , 2004, Cancer Research.

[11]  T. Kivelä,et al.  Very long-term prognosis of patients with malignant uveal melanoma. , 2003, Investigative ophthalmology & visual science.

[12]  K. Jöckel,et al.  Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities. , 2003, Cancer research.

[13]  I. Grierson,et al.  Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. , 2003, Investigative ophthalmology & visual science.

[14]  K. Bartz-Schmidt,et al.  Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. , 2001, Cancer research.

[15]  B. Horsthemke,et al.  Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. , 2000, Cancer genetics and cytogenetics.

[16]  D. Sidransky,et al.  Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. , 1999, Cancer Research.

[17]  D. Horsman,et al.  Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma , 1998, Cancer.

[18]  R. Rees,et al.  Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis , 1997, Genes, chromosomes & cancer.

[19]  N. Bornfeld,et al.  Prognostic implications of monosomy 3 in uveal melanoma , 1996, The Lancet.

[20]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[21]  H. V. van Peperzeel,et al.  Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. , 1982, Human pathology.